Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663286 · ClinicalTrials.gov registry record · Phase 3
A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
A Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,399
- Enrollment target
NCT00663286: Completed Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
NCT00663286 is a Phase 3 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 1,399 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00663286, a Phase 3 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,399 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Interventions
- DRUG Clindamycin
- DRUG Vehicle
- DRUG Benzoyl peroxide
- DRUG IDP-110
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,399 participants |
| Start Date | 2006-10 |
| Phase | Phase 3 |
What the finished NCT00663286 record still lists
NCT00663286 is an interventional study that assigns participants to a tested intervention. Its 1,399 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% higher).
The record links to 0 conditions, and to 4 interventions - of which Clindamycin is the first listed.
NCT00663286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00663286 about?
NCT00663286 is a clinical study titled "A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris". The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
What is the current status of trial NCT00663286?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,399 participants. The study started on 2006-10.
What interventions are being tested in trial NCT00663286?
The interventions under investigation include: Clindamycin (DRUG), Vehicle (DRUG), Benzoyl peroxide (DRUG), IDP-110 (DRUG).
Who is sponsoring clinical trial NCT00663286?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00663286's enrollment target sits among peer trials
1,399 175th of 2000 higher than 1,826 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia